BIIB 722 Mesylate

CAS No. 261505-81-1

BIIB 722 Mesylate( —— )

Catalog No. M37367 CAS No. 261505-81-1

BIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
10MG 657 In Stock
25MG 1026 In Stock
50MG 1386 In Stock
100MG 1832 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BIIB 722 Mesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    BIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.
  • Description
    BIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    261505-81-1
  • Formula Weight
    504.483
  • Molecular Formula
    C19H23F3N6O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC(=N)N)C1=CC=C(C(=C1)C(F)(F)F)N2CCN(C(=O)C3=CC=CN3)CC2.O=S(=O)(O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • QX-222 chloride

    QX222 is a sodium channel blocker.

  • SPX-101

    SPX-101 is a specific, peptide mimetic promoter of epithelial sodium channel (ENaC) internalization.

  • Nav1.8-IN-4

    Nav1.8-IN-4 is a potent Nav1.8 channel inhibitor with potential analgesic activity.Nav1.8-IN-4 can be used for pain and neurological related disorders.